A detailed history of Swan Capital LLC transactions in Pfizer Inc stock. As of the latest transaction made, Swan Capital LLC holds 11,102 shares of PFE stock, worth $278,993. This represents 0.16% of its overall portfolio holdings.

Number of Shares
11,102
Previous 11,102 -0.0%
Holding current value
$278,993
Previous $311 Million 3.43%
% of portfolio
0.16%
Previous 0.17%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $707 - $828
28 Added 0.25%
11,102 $311 Million
Q1 2024

Apr 30, 2024

BUY
$25.89 - $29.73 $7,042 - $8,086
272 Added 2.52%
11,074 $307 Million
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $12,124 - $15,748
464 Added 4.49%
10,802 $311 Million
Q3 2023

Oct 19, 2023

BUY
$32.09 - $37.51 $331,746 - $387,778
10,338 New
10,338 $343 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Swan Capital LLC Portfolio

Follow Swan Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swan Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Swan Capital LLC with notifications on news.